SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
apt12232-sup-0001-TableS1-FiguresS1-S3.docWord document736K

Table S1. Number of patients who experienced side effects from study drugs. (a) Vancomycin groups, (b) Metronidazole groups.

Figure S1. Change in total bilirubin in low- and high-dose vancomycin and metronidazole groups

Figure S2. Change in Mayo PSC risk score in low- and high-dose vancomycin and metronidazole groups

Figure S3. Difference between baseline and 12-week pruritus VAS score for individuals in each study group.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.